Yahata Takashi, Ando Kiyoshi, Miyatake Hiroko, Uno Tomoko, Sato Tadayuki, Ito Mamoru, Kato Shunichi, Hotta Tomomitsu
Division of Hematopoiesis, Research Center for Regenerative Medicine, Tokai University School of Medicine, Isehara, Kanagawa 259-1193, Japan.
Mol Ther. 2004 Nov;10(5):882-91. doi: 10.1016/j.ymthe.2004.07.029.
In multiunit cord blood transplantation, hematopoietic stem cells from each unrelated cord blood (UCB) unit competitively reconstitute the hematopoietic system in a recipient. To evaluate the fate of the progeny of each UCB unit and to determine the effects of graft-versus-graft reaction, we established a novel competitive repopulation assay using NOD/SCID/gammac(null) mice in which human T lymphocytes develop from CD34+ cells. CD34+ cells from each UCB unit were labeled with recombinant lentivirus vectors carrying genes encoding either enhanced green fluorescent protein (EGFP) or enhanced yellow fluorescent protein (EYFP). Hematopoietic chimerism composed of both EGFP+ and EYFP+ cells was stably maintained up to 6 months after transplantation with purified CD34+ cells; the ratio of EGFP+ to EYFP+ cells in peripheral blood and bone marrow posttransplantation was equivalent to the ratio of these cells at transplantation. However, when mononuclear cells from two UCB units were cotransplanted with CD34+ cells, engraftment was highly competitive, with cells from only one or the other of the two UCB units surviving. Further subfractionations of mononuclear cells indicate that the skewed chimerism that is often observed in clinical multiunit cord blood transplantation may be mediated by the cooperation of both CD4+ and CD8+ T cells. The assay established here will be a useful tool for analyzing hematopoietic reconstitution in clinical multiunit cord blood transplantation.
在多单位脐血移植中,来自每个无关脐血(UCB)单位的造血干细胞在受体中竞争性地重建造血系统。为了评估每个UCB单位子代的命运并确定移植物抗移植物反应的影响,我们利用NOD/SCID/γc(null)小鼠建立了一种新型的竞争性重建造模方法,在该小鼠中,人T淋巴细胞从CD34+细胞发育而来。来自每个UCB单位的CD34+细胞用携带编码增强型绿色荧光蛋白(EGFP)或增强型黄色荧光蛋白(EYFP)基因的重组慢病毒载体进行标记。在移植纯化的CD34+细胞后,由EGFP+和EYFP+细胞组成的造血嵌合体可稳定维持长达6个月;移植后外周血和骨髓中EGFP+细胞与EYFP+细胞的比例与移植时这些细胞的比例相当。然而,当来自两个UCB单位的单个核细胞与CD34+细胞共移植时,植入具有高度竞争性,只有两个UCB单位中的一个或另一个单位的细胞存活。单个核细胞的进一步亚分级表明,临床多单位脐血移植中经常观察到的偏向嵌合体可能是由CD4+和CD8+ T细胞的共同作用介导的。这里建立的检测方法将是分析临床多单位脐血移植中造血重建的有用工具。